|Awarded On||August 24, 2018|
|Title||Adolescent Vaccination Program (AVP): Expanding a Successful Clinic-based Multicomponent HPV Vaccination Program to the San Antonio Area|
|Award Mechanism||Expansion of Cancer Prevention Services to Rural and Medically Underserved Populations|
|Institution/Organization||The University of Texas Health Science Center at Houston|
|Principal Investigator/Program Director||Ross Shegog|
|Cancer Sites||Cervix Uteri, Head and Neck, HPV-related, Penis, Vagina, Vulva|
The goal of this proposed project is to assess the feasibility and effect of expanding the Adolescent Vaccination Program (AVP), a successful multi-level human papillomavirus (HPV) vaccination program, to another clinical network in Texas.
HPV is a major cause of morbidity and mortality in men and women that can be reduced through vaccination. Persistent infection with high-risk HPV types cause over 70% of cervical cancers, 90% of anal cancers, 60-70% of oropharyngeal cancers, and 40% of vagina, vulva, and penile cancers. Low-risk HPV types cause 90% of genital warts. HPV-related morbidity and mortality can be reduced through vaccination. Despite evidence of safety and efficacy, and endorsem...